Principal Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $227M | Buy |
1,793,779
+23,893
| +1% | +$3.15M | 0.11% | 177 |
|
|
2026
Q1 | $247M | Buy |
1,769,886
+7,880
| +0.4% | +$1.1M | 0.13% | 155 |
|
|
2025
Q4 | $216M | Buy |
1,762,006
+379,592
| +27% | +$46.1M | 0.11% | 172 |
|
|
2025
Q3 | $153M | Sell |
1,382,414
-18,461
| -1% | -$2.1M | 0.08% | 219 |
|
|
2025
Q2 | $155M | Sell |
1,400,875
-45,511
| -3% | -$4.84M | 0.08% | 212 |
|
|
2025
Q1 | $162M | Sell |
1,446,386
-8,272
| -0.6% | -$854K | 0.09% | 199 |
|
|
2024
Q4 | $134M | Buy |
1,454,658
+3,409
| +0.2% | +$307K | 0.07% | 232 |
|
|
2024
Q3 | $122M | Buy |
1,451,249
+59,181
| +4% | +$4.52M | 0.07% | 251 |
|
|
2024
Q2 | $95.5M | Sell |
1,392,068
-61,828
| -4% | -$4.13M | 0.06% | 272 |
|
|
2024
Q1 | $106M | Sell |
1,453,896
-5,656
| -0.4% | -$435K | 0.06% | 258 |
|
|
2023
Q4 | $118M | Sell |
1,459,552
-219,421
| -13% | -$17.1M | 0.08% | 220 |
|
|
2023
Q3 | $126M | Buy |
1,678,973
+107,844
| +7% | +$8.29M | 0.09% | 194 |
|
|
2023
Q2 | $121M | Buy |
1,571,129
+40,682
| +3% | +$3.24M | 0.08% | 214 |
|
|
2023
Q1 | $127M | Buy |
1,530,447
+14,092
| +0.9% | +$1.17M | 0.09% | 205 |
|
|
2022
Q4 | $130M | Sell |
1,516,355
-35,631
| -2% | -$2.82M | 0.1% | 200 |
|
|
2022
Q3 | $95.7M | Buy |
1,551,986
+59,861
| +4% | +$3.77M | 0.08% | 224 |
|
|
2022
Q2 | $92.2M | Sell |
1,492,125
-22,809
| -2% | -$1.41M | 0.07% | 243 |
|
|
2022
Q1 | $90.1M | Buy |
1,514,934
+40,869
| +3% | +$2.61M | 0.06% | 277 |
|
|
2021
Q4 | $107M | Sell |
1,474,065
-33,814
| -2% | -$2.33M | 0.06% | 257 |
|
|
2021
Q3 | $105M | Sell |
1,507,879
-7,564
| -0.5% | -$531K | 0.07% | 249 |
|
|
2021
Q2 | $104M | Buy |
1,515,443
+21,687
| +1% | +$1.45M | 0.07% | 254 |
|
|
2021
Q1 | $96.5M | Sell |
1,493,756
-121,635
| -8% | -$7.84M | 0.07% | 260 |
|
|
2020
Q4 | $94.1M | Sell |
1,615,391
-95,689
| -6% | -$5.77M | 0.07% | 260 |
|
|
2020
Q3 | $108M | Sell |
1,711,080
-92,092
| -5% | -$6.39M | 0.09% | 219 |
|
|
2020
Q2 | $139M | Buy |
1,803,172
+37,505
| +2% | +$2.87M | 0.12% | 185 |
|
|
2020
Q1 | $132M | Buy |
1,765,667
+12,068
| +0.7% | +$834K | 0.15% | 176 |
|
|
2019
Q4 | $114M | Sell |
1,753,599
-56,206
| -3% | -$3.66M | 0.09% | 241 |
|
|
2019
Q3 | $115M | Sell |
1,809,805
-7,825
| -0.4% | -$512K | 0.1% | 230 |
|
|
2019
Q2 | $123M | Sell |
1,817,630
-47,716
| -3% | -$3.14M | 0.11% | 217 |
|
|
2019
Q1 | $121M | Sell |
1,865,346
-171,449
| -8% | -$11.4M | 0.11% | 209 |
|
|
2018
Q4 | $127M | Sell |
2,036,795
-122,389
| -6% | -$8.55M | 0.14% | 186 |
|
|
2018
Q3 | $167M | Buy |
2,159,184
+7,548
| +0.4% | +$570K | 0.15% | 166 |
|
|
2018
Q2 | $152M | Sell |
2,151,636
-793,959
| -27% | -$56.1M | 0.14% | 176 |
|
|
2018
Q1 | $222M | Buy |
2,945,595
+148,398
| +5% | +$11.8M | 0.21% | 113 |
|
|
2017
Q4 | $200M | Sell |
2,797,197
-447,189
| -14% | -$34M | 0.18% | 128 |
|
|
2017
Q3 | $263M | Sell |
3,244,386
-664,719
| -17% | -$50.8M | 0.25% | 95 |
|
|
2017
Q2 | $277M | Buy |
3,909,105
+1,140,112
| +41% | +$75.9M | 0.28% | 82 |
|
|
2017
Q1 | $188M | Sell |
2,768,993
-623,067
| -18% | -$43.8M | 0.23% | 108 |
|
|
2016
Q4 | $243M | Buy |
3,392,060
+90,531
| +3% | +$6.73M | 0.31% | 72 |
|
|
2016
Q3 | $261M | Buy |
3,301,529
+151,455
| +5% | +$12.3M | 0.34% | 67 |
|
|
2016
Q2 | $263M | Sell |
3,150,074
-371,880
| -11% | -$33M | 0.37% | 58 |
|
|
2016
Q1 | $324M | Buy |
3,521,954
+515,481
| +17% | +$46.5M | 0.47% | 41 |
|
|
2015
Q4 | $304M | Sell |
3,006,473
-221,331
| -7% | -$23M | 0.45% | 38 |
|
|
2015
Q3 | $317M | Buy |
3,227,804
+251,293
| +8% | +$27.9M | 0.5% | 25 |
|
|
2015
Q2 | $348M | Buy |
2,976,511
+370,309
| +14% | +$40.5M | 0.52% | 21 |
|
|
2015
Q1 | $256M | Sell |
2,606,202
-416,080
| -14% | -$42.3M | 0.38% | 47 |
|
|
2014
Q4 | $285M | Buy |
3,022,282
+191,409
| +7% | +$19.8M | 0.44% | 32 |
|
|
2014
Q3 | $301M | Buy |
2,830,873
+152,146
| +6% | +$14.9M | 0.51% | 23 |
|
|
2014
Q2 | $222M | Sell |
2,678,727
-671,405
| -20% | -$52.3M | 0.37% | 47 |
|
|
2014
Q1 | $237M | Buy |
3,350,132
+6,869
| +0.2% | +$539K | 0.42% | 32 |
|
|
2013
Q4 | $251M | Buy |
3,343,263
+32,946
| +1% | +$2.29M | 0.47% | 25 |
|
|
2013
Q3 | $208M | Buy |
3,310,317
+760,018
| +30% | +$45.4M | 0.43% | 32 |
|
|
2013
Q2 | $131M | Buy |
+2,550,299
| New | +$133M | 0.29% | 78 |
|
Other funds holding GILD
Principal Financial Group's GILD Position: Q2 2026 in Review
Principal Financial Group increased its Gilead Sciences (GILD) stake by 1.3% in Q2 2026, buying an estimated $3.15M and bringing the position to 1,793,779 shares worth $227M. The position accounts for 0.11% of the portfolio, ranked #177.
Principal Financial Group first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $348M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Principal Financial Group held 1,793,779 shares of Gilead Sciences worth $227M as of Q2 2026.
- Principal Financial Group bought 23,893 Gilead Sciences shares in Q2 2026, an estimated $3.15M.
- Gilead Sciences made up 0.11% of Principal Financial Group's portfolio in Q2 2026, its #177 holding.
- Principal Financial Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Principal Financial Group's Gilead Sciences position peaked at $348M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.